UBS Group’s Alerian MLP Index ETNs due January 28 2044 AMJB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.13M Buy
61,845
+145
+0.2% +$5.07K ﹤0.01% 5063
2026
Q1
$2.13M Buy
61,700
+61,232
+13,084% +$2.04M ﹤0.01% 4915
2025
Q4
$14K Buy
+468
New +$13.9K ﹤0.01% 8026
2024
Q4
Sell
-2,428
Closed -$69.1K 10498
2024
Q3
$69.1K Sell
2,428
-697
-22% -$20K ﹤0.01% 6606
2024
Q2
$90.4K Buy
+3,125
New +$88.1K ﹤0.01% 6248

Other funds holding AMJB

UBS Group's AMJB Position: Q2 2026 in Review

UBS Group increased its Alerian MLP Index ETNs due January 28 2044 (AMJB) stake by 0.24% in Q2 2026, buying an estimated $5.07K and bringing the position to 61,845 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #5063.

UBS Group first reported a position in AMJB in Q2 2024 and has held it in 5 quarters since. 72 funds tracked by Wall St. Rank hold AMJB as of Q2 2026.

  • UBS Group held 61,845 shares of Alerian MLP Index ETNs due January 28 2044 worth $2.13M as of Q2 2026.
  • UBS Group bought 145 Alerian MLP Index ETNs due January 28 2044 shares in Q2 2026, an estimated $5.07K.
  • Alerian MLP Index ETNs due January 28 2044 made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5063 holding.
  • UBS Group first reported a position in Alerian MLP Index ETNs due January 28 2044 in Q2 2024 and has held it in 5 quarters since.
  • 72 funds tracked by Wall St. Rank held Alerian MLP Index ETNs due January 28 2044 as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.